74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Medifast Inc
Closed
Sector Consumer cyclical
14.67 2.37
Overview
Share price change
24h
Min
14.59
Max
14.88
Income | -327K 801K |
|---|---|
Sales | -21M 119M |
P/E Sector Avg | 21.328 35.729 |
EPS | 0.1 |
Profit margin | 0.673 |
EBITDA | -4.6M 709K |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +12.02 upside |
Next Earnings | 28 Apr 2025 |
|---|---|
Next Dividend date | 7 Mar 2025 |
Next Ex Dividend date | 24 Mar 2025 |
Market Cap | -20M 156M |
|---|---|
Previous open | 12.3 |
Previous close | 14.67 |
News Sentiment
By Acuity
55%
45%
328 / 385 Consumer cyclical
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Medifast Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Medifast Inc Forecast
Price Target
By TipRanks
12.02% upside
12 Months Forecast
Average 16.5 USD 12.02%
High 16.5 USD
Low 16.5 USD
Based on 1 Wall Street analysts offering 12 month price targets forMedifast Inc - Dist in the last 3 months.
Sentiment
By Acuity
328 / 385 Consumer cyclical
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Medifast Inc
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States and the Asia-Pacific. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
